Topics:
Breast Cancer • Medical Oncology • NCI-CCC Tumor Board Question • Yale • NCI-CCC Breast Tumor Board Question
In which situations are you comfortable with alternative dosing of ovarian suppression (e.g Lupron q3m) for premenopausal patients during adjuvant breast cancer treatment?
Answer from: Medical Oncologist at Academic Institution
My first option, when feasible/practical is to use every 4-week formulation of GNRH analog ovarian suppression treatment for hormone receptor-positive breast cancer. When that frequency of treatment presents a hardship, I generally feel comfortable with using ovarian suppression using depot GNRH ana...
Sign in or Register to read more
Answer from: Medical Oncologist at Community Practice
There is additional data supporting Q3month Goserelin (Wu et al., ESMO Open 2023). In this ESMO study, the E2 suppression rate was 98.96% in patients who received goserelin at 10.8 mg every 3 months compared with 92.71% in those who received a 3.6 mg dose every month (risk difference, 0.065; 95% CI,...
Comments
Medical Oncologist at Joliet Oncology Hematology Associates
What do you do if estradiol levels are high?
What do you do if estradiol levels are high?
Medical Oncologist at VanDeusen Oncology Consulting
Great question! I had posted some thoughts on this...
Great question! I had posted some thoughts on this...
Medical Oncologist at Joliet Oncology Hematology Associates
Very helpful
Very helpful